Absorbable medical devices based on novel films and foams made from semi-crystalline, segmented copolymers of lactide and epsilon-caprolactone exhibiting long term absorption characteristics

US10086109B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10086109-B2
Application numberUS-201514728177-A
CountryUS
Kind codeB2
Filing dateJun 2, 2015
Priority dateJun 2, 2015
Publication dateOct 2, 2018
Grant dateOct 2, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Absorbable medical devices based on novel foams and films made from semi-crystalline, segmented copolymers of lactide and epsilon-caprolactone exhibiting long term absorption characteristics are disclosed. Also disclosed are methods of producing said foams and films, and useful polymer solutions.

First claim

Opening claim text (preview).

We claim: 1. An absorbable foam, comprising a semi crystalline absorbable segmented copolymer, said copolymer comprising repeating units of polymerized lactide and polymerized epsilon-caprolactone, wherein the mole ratio of polymerized lactide to polymerized epsilon-caprolactone is between about 60:40 to about 75:25, said copolymer having a first heat Tg, as determined by differential scanning calorimetry at a scan rate of 10° C. per minute, equal to or less than 0° C., and a crystallinity level of about 20 percent to about 50 percent, as measured by wide angle X-ray diffraction, wherein the foam is made from a lyophilization solution having a solid content of between about 10 weight percent and 20 weight percent, and wherein the foam has a mechanical integrity at least 64 days post-implantation or having mechanical integrity after at least 64 days of incubation in a buffer of pH 7.27 at 37° C. 2. The foam of claim 1 having a thickness between about 40 mils and about 200 mils. 3. The foam of claim 1 , having a crystallinity level of about 25 percent to about 50 percent. 4. The foam of claim 1 , wherein the copolymer has an inherent viscosity at least about 0.5 dL/g, as measured in a 0.1 g/dl solution of HFIP at 25° C.

Assignees

Inventors

Classifications

  • Polyesters derived from hydroxycarboxylic acids, e.g. lactones (C08L67/06 takes precedence) · CPC title

  • Polyesters derived from hydroxy carboxylic acids, e.g. lactones (C08J2367/06 takes precedence) · CPC title

  • Biodegradable polymers · CPC title

  • the finished foam itself being a gel or a gel being temporarily formed when processing the foamable composition · CPC title

  • the liquid phase being organic · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10086109B2 cover?
Absorbable medical devices based on novel foams and films made from semi-crystalline, segmented copolymers of lactide and epsilon-caprolactone exhibiting long term absorption characteristics are disclosed. Also disclosed are methods of producing said foams and films, and useful polymer solutions.
Who is the assignee on this patent?
Ethicon Inc
What technology area does this patent fall under?
Primary CPC classification C08J9/26. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).